176 related articles for article (PubMed ID: 8921807)
1. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion.
Takahashi N; Reinhardt CP; Marcel R; Leppo JA
Circulation; 1996 Nov; 94(10):2605-13. PubMed ID: 8921807
[TBL] [Abstract][Full Text] [Related]
2. Correlations between uptake of technetium-99m Q12 and thallium-201: myocardial perfusion and viability in a model of acute coronary reperfusion.
Takahashi N; Reinhardt CP; Marcel R; Leppo JA
J Nucl Med; 1998 Jan; 39(1):159-65. PubMed ID: 9443756
[TBL] [Abstract][Full Text] [Related]
3. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA
Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201.
Takahashi N; Dahlberg ST; Gilmore MP; Leppo JA
J Nucl Cardiol; 1997; 4(6):524-31. PubMed ID: 9456193
[TBL] [Abstract][Full Text] [Related]
5. Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?
Caner B; Beller GA
Clin Cardiol; 1998 Apr; 21(4):235-42. PubMed ID: 9562932
[TBL] [Abstract][Full Text] [Related]
6. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow.
Glover DK; Ruiz M; Yang JY; Smith WH; Watson DD; Beller GA
Circulation; 1997 Oct; 96(7):2332-8. PubMed ID: 9337208
[TBL] [Abstract][Full Text] [Related]
7. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
8. Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult.
Canby RC; Silber S; Pohost GM
Circulation; 1990 Jan; 81(1):289-96. PubMed ID: 2137046
[TBL] [Abstract][Full Text] [Related]
9. Myocardial redistribution of technetium-99m-methoxyisobutyl isonitrile (SESTAMIBI).
Li QS; Solot G; Frank TL; Wagner HN; Becker LC
J Nucl Med; 1990 Jun; 31(6):1069-76. PubMed ID: 2140856
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
[TBL] [Abstract][Full Text] [Related]
11. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
12. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
Chareonthaitawee P; O'Connor MK; Gibbons RJ; Ritman EL; Christian TF
Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805
[TBL] [Abstract][Full Text] [Related]
13. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
[TBL] [Abstract][Full Text] [Related]
14. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction.
Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G
J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of myocardial viability using perfusion cardiac SPECT. 201-thallium rest/redistribution, 201-thallium rest/reinjection and technetium 99m tetrofosmin rest/postnitrates].
Flotats Giralt A; Carrió Gasset I; Estorch Cabrera M; Bernà Roqueta L; Catafau Alcántara AM; Marí Aparici C; Ballester Rodés M
Rev Esp Cardiol; 1998; 51 Suppl 1():45-52. PubMed ID: 9549398
[TBL] [Abstract][Full Text] [Related]
16. Myocardial transport of hexakis(2-methoxyisobutylisonitrile) and thallium before and after coronary reperfusion.
Meerdink DJ; Leppo JA
Circ Res; 1990 Jun; 66(6):1738-46. PubMed ID: 2140539
[TBL] [Abstract][Full Text] [Related]
17. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.
Vanzetto G; Calnon DA; Ruiz M; Watson DD; Pasqualini R; Beller GA; Glover DK
Circulation; 1997 Oct; 96(7):2325-31. PubMed ID: 9337207
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
19. Myocardial uptake of thallium 201 and technetium 99m-labeled sestamibi after ischemia and reperfusion: comparison by quantitative dual-tracer autoradiography in rabbits.
Weinstein H; Reinhardt CP; Wironen JF; Leppo JA
J Nucl Cardiol; 1994; 1(4):351-64. PubMed ID: 9420718
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-labeled myocardial perfusion agents: Are they better than thallium-201?
Kailasnath P; Sinusas AJ
Cardiol Rev; 2001; 9(3):160-72. PubMed ID: 11304401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
